Deramiocel

2 trends tracked about this subject — the full history, oldest to newest below.

↓ Cooling Business 🔮 fades

FDA staff flags data concerns about Capricor's therapy; shares plunge

Capricor Therapeutics faces market volatility and legal investigations following the release of FDA staff documents regarding its therapy, Deramiocel.

4 sources 5 articles v 3 10h ago

↑ Rising Business 🔮 fades

Ahead of hearing, FDA questions the efficacy of Capricor’s Duchenne drug

FDA staff have raised significant concerns regarding the efficacy data for Capricor Therapeutics' experimental heart disease therapy for Duchenne patients.

10 sources 11 articles v 9 7h ago